1. Analysis of Sustained Viral Response and Boceprevir Resistance Following Combination Treatment With Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in HCV Genotype 1 Prior Relapsers And Nonresponders

2. Study Design

3. SVR and Relapse Rates Are Consistent With RESPOND 2

5. Objective

6. Methodology for Resistance Analysis

7. Amino Acid Residues Associated With Resistance Can Directly or Indirectly Influence Boceprevir Binding

8. Non-SVR Patients With Postbaseline RAVs Detected: Distribution by Treatment Response Category

9. Non-SVR Patients With Post-baseline RAVs Detected: Distribution by Resistance Locus

10. Virological Response Curves for Non-SVR Patients With Postbaseline RAVs

11. SVR Based on TW4 Lead-in Response (Overall Study – BOC Arm)

12. RAVs Detected in Non-SVR Interferon Responders and Nonresponders

13. Summary

14. Acknowledgements